Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II RCT of Qutenza vs amitriptyline for neuropathic pain after head and neck (ORL) cancer remission
2020-003965-21Phase 2Active
- Sponsor
- Institut Claudius Regaud
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of capsaicin in Neuralgia (2 arms), sponsored by Institut Claudius Regaud. Primary endpoint: Pain response at 9 months. Started Oct 2020; status: active.
02
Drugs
capsaicin
03
Conditions
Neuralgia
Beyond the preview
Go deeper on 2020-003965-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003965-21.